Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 84751 - 84775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Troglitazone	Approved Withdrawn	BUB1	699	downregulated	troglitazone results in decreased expression of BUB1 mRNA	2q13	A24633
Troglitazone	Approved Withdrawn	BUB1B	701	downregulated	troglitazone results in decreased expression of BUB1B mRNA	15q15.1	A24633
Troglitazone	Approved Withdrawn	C3	718	downregulated	troglitazone results in decreased expression of C3 mRNA	19p13.3	A22609
Troglitazone	Approved Withdrawn	C8A	731	downregulated	troglitazone results in decreased expression of C8A mRNA	1p32.2	A22609
Troglitazone	Approved Withdrawn	C8B	732	downregulated	troglitazone results in decreased expression of C8B mRNA	1p32.2	A22609
Troglitazone	Approved Withdrawn	C8G	733	downregulated	troglitazone results in decreased expression of C8G mRNA	9q34.3	A22609
Troglitazone	Approved Withdrawn	CA12	771	upregulated	troglitazone results in increased expression of CA12 mRNA	15q22.2	A22609
Troglitazone	Approved Withdrawn	CALML4	91860	downregulated	troglitazone results in decreased expression of CALML4 mRNA	15q23	A22609
Troglitazone	Approved Withdrawn	CASP10	843	upregulated	troglitazone results in increased expression of CASP10 mRNA	2q33.1	A24107
Troglitazone	Approved Withdrawn	CASP8	841	downregulated	troglitazone results in decreased expression of CASP8 mRNA	2q33.1	A24107
Troglitazone	Approved Withdrawn	CASP8	841	upregulated	troglitazone results in increased expression of CASP8 mRNA	2q33.1	A24107
Troglitazone	Approved Withdrawn	CAT	847	upregulated	troglitazone results in increased expression of CAT mRNA	11p13	A24107
Troglitazone	Approved Withdrawn	CBX1	10951	downregulated	troglitazone results in decreased expression of CBX1 mRNA	17q21.32	A24633
Troglitazone	Approved Withdrawn	CCL2	6347	downregulated	troglitazone results in decreased expression of CCL2 mRNA	17q12	A24633
Troglitazone	Approved Withdrawn	CCL20	6364	upregulated	troglitazone results in increased expression of CCL20 mRNA	2q36.3	A24633
Troglitazone	Approved Withdrawn	CCL3	6348	downregulated	troglitazone results in decreased expression of CCL3 mRNA	17q12	A24107
Troglitazone	Approved Withdrawn	CCL3	6348	upregulated	troglitazone results in increased expression of CCL3 mRNA	17q12	A24107
Troglitazone	Approved Withdrawn	CCL4	6351	downregulated	troglitazone results in decreased expression of CCL4 mRNA	17q12	A24107 A24636
Troglitazone	Approved Withdrawn	CCL4	6351	upregulated	troglitazone results in increased expression of CCL4 mRNA	17q12	A24107
Troglitazone	Approved Withdrawn	CCL5	6352	upregulated	troglitazone results in increased expression of CCL5 mRNA	17q12	A24633
Troglitazone	Approved Withdrawn	CCNA2	890	downregulated	troglitazone results in decreased expression of CCNA2 mRNA	4q27	A24633
Troglitazone	Approved Withdrawn	CCNB1	891	downregulated	troglitazone results in decreased expression of CCNB1 mRNA	5q13.2	A24633
Troglitazone	Approved Withdrawn	CCNB2	9133	downregulated	troglitazone results in decreased expression of CCNB2 mRNA	15q22.2	A24633
Troglitazone	Approved Withdrawn	CCND1	595	downregulated	troglitazone results in decreased expression of CCND1 mRNA	11q13.3	A24642 A24639 A20877
Troglitazone	Approved Withdrawn	CCND1	595	upregulated	troglitazone results in increased expression of CCND1 mRNA	11q13.3	A22275

Displaying entries 84751 - 84775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability